PESERICO, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 304
EU - Europa 25
AS - Asia 19
Totale 348
Nazione #
US - Stati Uniti d'America 302
SG - Singapore 10
FI - Finlandia 8
CN - Cina 6
SE - Svezia 4
BG - Bulgaria 3
FR - Francia 3
GB - Regno Unito 3
DE - Germania 2
CA - Canada 1
ID - Indonesia 1
IN - India 1
IT - Italia 1
MX - Messico 1
MY - Malesia 1
PT - Portogallo 1
Totale 348
Città #
Fairfield 63
Houston 40
Seattle 27
Ann Arbor 23
Woodbridge 23
Chandler 17
Wilmington 16
Cambridge 13
Ashburn 11
Singapore 9
Princeton 8
Boardman 6
San Diego 5
Des Moines 4
Jacksonville 4
Helsinki 3
Norwalk 3
Sofia 3
Hebei 2
Jiaxing 2
Medford 2
Roxbury 2
Bloomfield 1
Edinburgh 1
Kilburn 1
Kuala Lumpur 1
Lansing 1
Lisbon 1
Mexico City 1
Nanjing 1
Padova 1
Santa Clara 1
Tianjin 1
Vancouver 1
Totale 298
Nome #
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. 102
Etanercept provides a more physiological approach in the treatment of psoriasis. 69
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. 66
Cerebral blood flow changes induced by electrical stimulation of the Gasserian ganglion after experimentally induced subarachnoid haemorrhage in pigs. 64
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. 44
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 5
Totale 350
Categoria #
all - tutte 1.438
article - articoli 1.438
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035 0 0 0 0 0 0 8 8 8 4 5 2
2020/202133 3 0 3 5 0 0 2 5 4 4 4 3
2021/202284 5 8 17 11 2 3 2 11 2 1 11 11
2022/202340 8 4 0 3 7 10 0 2 3 0 3 0
2023/202413 2 6 0 0 0 0 1 0 0 0 3 1
2024/202530 0 6 3 5 10 5 1 0 0 0 0 0
Totale 350